SPONSOR
Gruppo Oncologico Italiano di Ricerca Clinica
Total Trials
2
Recruiting
2
Phases
Phase 3
Gruppo Oncologico Italiano di Ricerca Clinica is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Mesotheliomas Pleural, NSCLC (Advanced Non-small Cell Lung Cancer), HER2.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Gruppo Oncologico Italiano di Ricerca Clinica
How many clinical trials has Gruppo Oncologico Italiano di Ricerca Clinica sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Gruppo Oncologico Italiano di Ricerca Clinica, of which 2 are actively recruiting participants. These trials cover conditions including Mesotheliomas Pleural, NSCLC (Advanced Non-small Cell Lung Cancer), HER2. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Gruppo Oncologico Italiano di Ricerca Clinica research focus on?
Gruppo Oncologico Italiano di Ricerca Clinica clinical trials span Mesotheliomas Pleural, NSCLC (Advanced Non-small Cell Lung Cancer), HER2. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Gruppo Oncologico Italiano di Ricerca Clinica clinical trial?
To participate in a Gruppo Oncologico Italiano di Ricerca Clinica trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Gruppo Oncologico Italiano di Ricerca Clinica trials with current recruitment status updated daily.
Clinical Trials by Gruppo Oncologico Italiano di Ricerca Clinica
NCT04996017 Phase 3
Recruiting
Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)
Mesotheliomas Pleural
NCT07356544
Recruiting
Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in aNSCLC
NSCLC (Advanced Non-small Cell Lung Cancer)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology